Cargando…

Clinical features and KRAS mutation in colorectal cancer with bone metastasis

Bone metastasis is known as a poor prognostic factor in colorectal cancer (CRC), but its clinical manifestations and outcomes are uncertain. CRC with bone metastasis was searched from January 2006 to April 2016. Of 11,551 CRC patients, 321 (2.7%) patients had bone metastasis. Bone-only metastasis wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyung Soon, Chun, You Jin, Kim, Han Sang, Kim, Jee Hung, Lee, Choong-kun, Beom, Seung-Hoon, Shin, Sang Joon, Ahn, Joong Bae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713114/ https://www.ncbi.nlm.nih.gov/pubmed/33273596 http://dx.doi.org/10.1038/s41598-020-78253-x

Ejemplares similares

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
por: Kim, Chang Gon, et al.
Publicado: (2016)

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Se Hyun, et al.
Publicado: (2016)

Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study – (NCT05103020) – study protocol
por: Kim, Ji Su, et al.
Publicado: (2023)

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
por: Kim, Yeo-Eun, et al.
Publicado: (2016)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value
por: Ahn, Hong-Min, et al.
Publicado: (2023)

Colorectal Cancer Prognosis Is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study
por: Lee, Joon-Hyop, et al.
Publicado: (2019)

Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells
por: Cheon, Seul‐Ki, et al.
Publicado: (2018)

Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection
por: Park, Kyung Hee, et al.
Publicado: (2021)

Rapid and accurate detection of KRAS mutations in colorectal cancers using the isothermal-based optical sensor for companion diagnostics
por: Jin, Choong Eun, et al.
Publicado: (2017)

Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
por: Park, Ji Soo, et al.
Publicado: (2019)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors
por: Lee, Ji Hyun, et al.
Publicado: (2022)

Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659
por: Lee, Ji Hyun, et al.
Publicado: (2022)

The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
por: Kim, Jun Won, et al.
Publicado: (2010)

Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis
por: Kim, Hyunjung, et al.
Publicado: (2019)

IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
por: ZANATTO, Renato Morato, et al.
Publicado: (2020)

Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation
por: Lee, Hyoun Wook, et al.
Publicado: (2022)

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023)

Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer
por: Choi, Jeesoo, et al.
Publicado: (2022)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)

Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea
por: Beom, Seung-Hoon, et al.
Publicado: (2022)

High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
por: Lee, Ha-young, et al.
Publicado: (2014)

Association between KRAS mutation and lung metastasis in advanced colorectal cancer
por: Pereira, A A L, et al.
Publicado: (2015)

CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
por: Kim, Se Hyun, et al.
Publicado: (2018)

Repeat hepatectomy for recurred colorectal liver metastasis: is it justified?
por: Park, Jangho, et al.
Publicado: (2019)

Investigation of the Trajectory of Muscle and Body Mass as a Prognostic Factor in Patients With Colorectal Cancer: Longitudinal Cohort Study
por: Seo, Dongjin, et al.
Publicado: (2023)

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
por: Lee, Jii Bum, et al.
Publicado: (2020)

Robust performance of deep learning for distinguishing glioblastoma from single brain metastasis using radiomic features: model development and validation
por: Bae, Sohi, et al.
Publicado: (2020)

Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
por: Kim, Seung Tae, et al.
Publicado: (2014)

Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers
por: Kim, Han Sang, et al.
Publicado: (2023)

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis
por: Kim, Hae Su, et al.
Publicado: (2016)

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
por: Kim, Seung Tae, et al.
Publicado: (2015)

Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases
por: Kim, Ki-Yeol, et al.
Publicado: (2015)

Solo Intracorporeal Esophagojejunostomy Reconstruction Using a Laparoscopic Scope Holder in Single-Port Laparoscopic Total Gastrectomy for Early Gastric Cancer
por: Ahn, Sang-Hoon, et al.
Publicado: (2015)

Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasis
por: Son, Sang-Yong, et al.
Publicado: (2013)

MICA (∗)012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer
por: Ding, Weifeng, et al.
Publicado: (2020)

Can the presence of KRAS mutations guide the type of liver resection during simultaneous resection of colorectal liver metastasis?
por: Choi, Munseok, et al.
Publicado: (2022)

Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
por: Lee, Jii Bum, et al.
Publicado: (2021)

L1 Cell Adhesion Molecule Expression Is Associated With Pelvic Lymph Node Metastasis and Advanced Stage in Diabetic Patients With Endometrial Cancer: A Matched Case Control Study
por: Suh, Dong Hoon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_80f99joas92s4v3k1la12oecpc